The FDA approves two innovative nonmedication treatment options that offer new hope for PTSD patients.

FDA approval of centanafadine provides new ADHD treatment option for children, adolescents, and adults.

Otsuka's FDA approval of an ADHD drug opens an entirely new drug class, expanding treatment options for patients.

Scientists identify a potential 'sixth sense' mechanism that could unlock new understanding of mental health.

New VA trial of MDMA-assisted therapy for PTSD offers veterans promising hope for mental health treatment.

Growing recognition of mental health's critical role in managing chronic disease.

Probiotics show promising potential for naturally supporting anxiety relief and mental health.

Mental health awareness and community discussion promotes better patient care.

Wisconsin lab advances promising psychedelic research for mental health treatment options.

A New York healthcare company has developed a scalable breakthrough in behavioral health treatment.

New legislation advances FDA-approved psilocybin treatment option for patients in need.

Policy initiative to accelerate psychedelic drug research for mental health treatment.

Executive order expedites FDA review of psychedelics for treating mental health disorders.

Executive order accelerates legal access to psychedelics for mental health treatment.

New VA law prepares to implement FDA-approved psychedelic treatments for veterans.

Legislation aims to advance psychedelics research for treating veterans with mental health conditions.

Medical student inspired by personal experience pursues psychiatric research to help others.

FDA approval of new bipolar disorder and schizophrenia treatment offers patients an additional therapeutic option.